• Nenhum resultado encontrado

[PDF] Top 20 Fexinidazole: A Potential New Drug Candidate for Chagas Disease

Has 10000 "Fexinidazole: A Potential New Drug Candidate for Chagas Disease" found on our website. Below are the top 20 most common "Fexinidazole: A Potential New Drug Candidate for Chagas Disease".

Fexinidazole: A Potential New Drug Candidate for Chagas Disease

Fexinidazole: A Potential New Drug Candidate for Chagas Disease

... the disease to confirm the therapeutic efficacy of fexinidazole as observed in the first and second ...and fexinidazole was administered on day 120 post-infection for 20 consecutive ...after ... See full document

9

Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease

Antitrypanosomal Activity of Fexinidazole Metabolites, Potential New Drug Candidates for Chagas Disease

... sulfone fexinidazole metabolites following oral administra- tion in a murine model of Chagas ...doses. Fexinidazole metabolites were effective in reducing the numbers of circulating para- sites and ... See full document

9

Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease.

Utilizing Chemical Genomics to Identify Cytochrome b as a Novel Drug Target for Chagas Disease.

... for new drug discovery efforts aimed at treating kinetoplastid ...of drug targets for these diseases. For Chagas disease, only sterol 14α-demethylase (CYP51) and cruzain have been ... See full document

22

Chemical mechanism of UDP-galactopyranose mutase from Trypanosoma cruzi: a potential drug target against Chagas' disease.

Chemical mechanism of UDP-galactopyranose mutase from Trypanosoma cruzi: a potential drug target against Chagas' disease.

... or Chagas’ ...this disease in South and Central America ...of new inhibitors that function as novel antiparasitic drugs for the treatment of Chagasdisease ... See full document

11

In Vitro and in Vivo Trypanocidal Effects of the Cyclopalladated Compound 7a, a Drug Candidate for Treatment of Chagas' Disease

In Vitro and in Vivo Trypanocidal Effects of the Cyclopalladated Compound 7a, a Drug Candidate for Treatment of Chagas' Disease

... ideal drug, with its efficacy and tolerance being inversely related to the age of the patient ...other drug clinically available was Nifurti- mox, but it has been discontinued from Bayer’s production ... See full document

8

Electrochemical Reduction Using Glassy Carbon Electrode in Aqueous Medium of a Potential Anti-Chagas Drug: NFOH

Electrochemical Reduction Using Glassy Carbon Electrode in Aqueous Medium of a Potential Anti-Chagas Drug: NFOH

... Some new nitroheterocyclic compounds have been proposed as candidate drugs for Chagasdisease chemotherapy, 3-6 some of which have a trypanocidal action due to their ability to be reduced by ... See full document

5

Antigenicity and diagnostic potential of vaccine candidates in human Chagas disease.

Antigenicity and diagnostic potential of vaccine candidates in human Chagas disease.

... of Chagas disease is frequently based on tests such as enzyme-linked immunoassays (EIAs), indirect immunofluorescence assays, and indirect haemagglutination assays ...and Drug Administration for use ... See full document

10

In vitro and in vivo experimental models for drug screening and development for Chagas disease

In vitro and in vivo experimental models for drug screening and development for Chagas disease

... the disease (Rocha et ...of new trypanocidal com- pounds to replace these current ...to potential preclinical experimental hosts shall be con- ...a drug screening ... See full document

6

In vitro and in vivo experimental models for drug screening and development for Chagas disease

In vitro and in vivo experimental models for drug screening and development for Chagas disease

... the disease (Rocha et ...of new trypanocidal com- pounds to replace these current ...to potential preclinical experimental hosts shall be con- ...a drug screening ... See full document

6

Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of chagas disease.

Ruthenium complex with benznidazole and nitric oxide as a new candidate for the treatment of chagas disease.

... These drugs have been used for more than 50 years. Treatment with Bz during the acute phase of the disease is able to cure approximately 60% of the patients. However, the cure rates do not exceed 20% when Bz is ... See full document

7

Ergosterol biosynthesis and drug development for Chagas disease

Ergosterol biosynthesis and drug development for Chagas disease

... of Chagas disease; herein we discuss their limitations along with potential alternatives with a focus on ergosterol biosynthesis inhibitors ...compounds, new triazole derivatives that inhibit ... See full document

8

J. Braz. Chem. Soc.  vol.25 número10

J. Braz. Chem. Soc. vol.25 número10

... Chagas disease is caused by the parasite Trypanosoma cruzi and affects approximately eight million individuals in the developing world; it is also classified as a neglected tropical disease by the ... See full document

19

Vector control intervention towards interruption of transmission of Chagas disease by Rhodnius prolixus, main vector in Guatemala

Vector control intervention towards interruption of transmission of Chagas disease by Rhodnius prolixus, main vector in Guatemala

... vector-borne disease control programme [Enfermedades Transmitidas por Vectores (ETV)] of each department investigated houses with the risk ...about Chagas disease and the physical appearance of the ... See full document

12

MC Sánchez-Guillén, C Barnabé, JF Guégan, M Tibayrenc, M Velásquez-Rojas, J Martínez-Munguía, H Salgado-Rosas, E Torres-Rasgado, MI Rosas-Ramírez, R Pérez-Fuentes+

MC Sánchez-Guillén, C Barnabé, JF Guégan, M Tibayrenc, M Velásquez-Rojas, J Martínez-Munguía, H Salgado-Rosas, E Torres-Rasgado, MI Rosas-Ramírez, R Pérez-Fuentes+

... In Mexico, the infection by T. cruzi is mainly silent. Thus, like in most countries of Latin America, Chagas dis- ease has become an urban disease, due to the migration of people from endemic areas to the ... See full document

6

Rev. Bras. Cardiol. Invasiva  vol.20 número2 en a03v20n2

Rev. Bras. Cardiol. Invasiva vol.20 número2 en a03v20n2

... in drug- eluting balloon technology. One is the drug, the other is the balloon catheter, and the last is the excipient that binds the drug to the balloon catheter surface and releases it to the ... See full document

2

Review Article Electrocardiogram in Chagas disease

Review Article Electrocardiogram in Chagas disease

... 49. Moraes DNM, Nascimento BR, Beaton AZ, Soliman EZ, Lima- Costa MF, dos Reis RCP, et al. Value of the electrocardiographic (P Wave, T Wave, QRS) axis as a predictor of mortality in 14 years in a population with a high ... See full document

8

DARC AND CHAGAS’ DISEASE

DARC AND CHAGAS’ DISEASE

... IL-8 is involved in the monocyte and neutrophil recruitment and activation process for sites of acute inflammatory response. It presents certain longevity in these sites, being produced at the beginning of inflammatory ... See full document

7

CD17.R31: Chagas' disease

CD17.R31: Chagas' disease

... of Chagas' disease in the Americas, based on available information and such other information as may be obtained from particular studies that are undertaken subject to the availability of budgetary ... See full document

2

Immunopathology of Chagas Disease

Immunopathology of Chagas Disease

... The auto-immune theory is supported by the lack of correlation between parasitism and chronic myocarditis. However, the great age variation of the patients at the onset of clinical manifestations, the lack of ... See full document

10

Pupillometry in Chagas disease

Pupillometry in Chagas disease

... We studied 160 eyes in the Chagas group and 152 eyes in the control group. Participants were asked to abstain from caffeine or other stimulants for 12 hours prior to the examination. The study was performed in a ... See full document

7

Show all 10000 documents...